Design Controls Could Increase Manufacturer Liability, Attorney Suggests
This article was originally published in The Gray Sheet
Wider adoption of design controls in the development of medical devices, while speeding product approval times, potentially exposes manufacturers to greater risk in product liability lawsuits, according to attorney Jeffrey Gibbs of the Washington D.C. law firm of Hyman, Phelps and McNamara.
You may also be interested in...
Canada has announced new restrictions on exports to help mitigate the impact of measures in the US to lower medicine prices there.
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.